Skip to main content

Animations

MJFF Publications

1401 - 1410 of 6568 Results
Title
Year
  • Year
  • 2026
  • 2026
  • 2026
  • 2026
  • 2021
  • 2021
  • 2021
  • 2021
  • 2026
  • 2026
  • Summary Details
    OPEN
    Title: Long-Term Use of Tiapride and Tetrabenazine in Huntington’s Disease: A 25-Year Retrospective Single-Center Analysis
    Journal Name: Clinical Therapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clinthera.2026.05.005
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Chemical tools for inhibition and activity-based profiling of glucocerebrosidase in vitro and in vivo
    Journal Name: Cell Chemical Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.chembiol.2026.07.007
    Citation Count: 0
  • Summary Details
    OPEN
    Title: STING dampens the unfolded protein response to enable the presentation of self-antigens on MHC-I during inflammation
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2026.117497
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The structural basis for LRRK2’s activation and autoinhibition
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cell.2026.07.027
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.626974
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Safety and Tolerability of Burst-Cycling Deep Brain Stimulation for Freezing of Gait in Parkinson’s Disease
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2021.651168
    Citation Count: 11
  • Summary Details
    OPEN
    Title: TP53INP1 exerts neuroprotection under ageing and Parkinson’s disease-related stress condition
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-021-03742-4
    Citation Count: 22
  • Summary Details
    OPEN
    Title: DNA Methylation and Expression Profiles of Whole Blood in Parkinson’s Disease
    Journal Name: Frontiers in Genetics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fgene.2021.640266
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Exploring the association between antidepressants, progression and mortality in Huntington’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awag009
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Benzoxaboroles Are Structurally Unique Binders of Eukaryotic Translation Initiation Factor 4E
    Journal Name: Journal of the American Chemical Society
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/jacs.6c04291
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.